The efficient preparation of α-substituted serine scaffolds as the chiral building blocks for the synthesis of SPT inhibitors

Tetrahedron

Volumn 63, Issue 43, 2007, Pages 10603-10607

  Martinková, Miroslava ^a   Gonda, Jozef ^a   Raschmanová, Jana ^a   Vojtičková, Margaréta ^a  

^a P J AFÁRIK UNIVERSITY   (Slovakia)

Author keywords

[No Author keywords available]

Indexed keywords

1,3 BUTANEDIOL; 4 O ACETYL 2 BENZOYLOXYMETHYL 2 (METHOXYCARBONYLAMINO) 1,3 BUTANEDIOL; 4 O ACETYL 2 BENZOYLOXYMETHYL 3 O FORMYL 2 (METHOXYCARBONYLAMINO)BUTANOIC ACID; 5 O ACETYL 3 C BENZOYLOXYMETHYL 3 DEOXY 3 METHOXYCARBONYLAMINO DEXTRO XYLOFURANOSE; 7 O ACETYL 5 BENZOYLOXYMETHYL 4,6 DIHYDROXY 5 (METHOXYCARBONYLAMINO)HEPT 2 ENOATE; BUTYRIC ACID DERIVATIVE; FURAN DERIVATIVE; FURANOSE; SERINE DERIVATIVE; SERINE PALMITOYLTRANSFERASE; SERINE PALMITOYLTRANSFERASE INHIBITOR; UNCLASSIFIED DRUG;

ARTICLE; CHEMICAL STRUCTURE; CHIRALITY; PRIORITY JOURNAL; STEREOCHEMISTRY; SYNTHESIS;

EID: 34548495599     PISSN: 00404020     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tet.2007.08.019     Document Type: Article

References (24)

1. Zweerink M.M., Edison A.M., Wells G.B., Pinto W., and Lester R.L. J. Biol. Chem. 267 (1992) 25032
2. Chen J.K., Lane W.S., and Schreiber S.L. Chem. Biol. 6 (1999) 221
3. Hanada K. Biochim. Biophys. Acta 1632 (2003) 16
4. Hakomori S. J. Biol. Chem. 265 (1990) 18713
5. Van Meer G., and Burger K.N.J. Trends Cell Biol. 2 (1992) 332
6. In: Siegel G.J., Agranoff B.W., Albers R.W., Fisher S.K., and Uhler M.D. (Eds). Basic Neurochemistry, Molecular, Cellular and Medical Aspects. 6th ed. (1999), Lippincott Williams and Wilkins, Philadelphia, PA 47
7. Liao J., Tao J., Lin G., and Liu D. Tetrahedron 61 (2005) 4715
8. Byun H.-S., Lu X., and Bittman R. Synthesis (2006) 2447
9. Delgado A., Casas J., Llebaria A., Abad J.L., and Fabrias G. Biochim. Biophys. Acta 1758 (2006) 1957
10. Oishi T., Ando K., Inomiya K., Sato H., Iida M., and Chida N. Bull. Chem. Soc. Jpn. 75 (2002) 1927
11. Trost B.M., and Lee C. J. Am. Chem. Soc. 123 (2001) 12191
12. Nakamura T., and Shiozaki M. Tetrahedron Lett. 42 (2001) 2701
13. Lee K.-Y., Oh Ch.-Y., and Ham W.-H. Org. Lett. 4 (2002) 4403
14. Nakamura T., and Shiozaki M. Tetrahedron 58 (2002) 8779
15. For biological activity of myriocin:. Miyake Y., Kozutsumi Y., Nakamura S., Fujita T., and Kawasaki T. Biochem. Biophys. Res. Commun. 211 (1995) 396
16. Ikushiro H., Hayashi H., and Kagamiyama H. Biochemistry 43 (2004) 1082
17. Cativela C., and Díaz-de-Villegas M.D. Tetrahedron: Asymmetry 11 (2000) 645
18. Gonda J., Martinková M., Raschmanová J., and Balentová E. Tetrahedron: Asymmetry 17 (2006) 1875
19. Martinková M., Gonda J., and Raschmanová J. Molecules 11 (2006) 564
20. Kolb H.C., Ley S.V., Slawin M.Z., and Williams D.J. J. Chem. Soc., Perkin Trans. 1 (1992) 2735
21. Yoshimura J., Hara K., Yamaura M., Mikami K., and Hashomoto H. Bull. Chem. Soc. Jpn. 55 (1982) 933
22. Muto S., and Mori K. Eur. J. Org. Chem. (2001) 4635
23. Kiuchi M., Adachi K., Kohara T., Minoguchi M., Hanano T., Aoki Y., Mishina T., Arita M., Nakao N., Ohtsuki M., Hoshino Y., Teshima K., Chiba K., Sasaki S., and Fujita T. J. Med. Chem. 43 (2000) 2946
24. Matsumoto N., Kohno T., Uchida S., Shomizu T., Kusumuto H., Hirose R., Yanada K., Kurio W., Yamaguchi S., Watabe K., and Fujita T. Bioorg. Med. Chem. 14 (2006) 4182